Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
FUJIFILM
Sort By
Newest First
1 / 1
Facility Acquisition
Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
Fujifilm Diosynth Biotechnologies
PR-M04-22-01
Apr 04, 2022
Facility Acquisition
Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
Fujifilm Diosynth Biotechnologies
PR-M01-22-18
Jan 26, 2022
Strategic Alliance
FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve the Drug Discovery Process
FUJIFILM
PR-M01-22-05
Jan 06, 2022
Partnership
Fujifilm Partners with Dr. Reddy's and Global Response Aid for Deployment of a COVID-19 Treatment Drug Outside of Japan
Nice Insight
PR-M06-20-NI-043
Jul 02, 2020
Liposome Formulations
FUJIFILM Toyama Chemical Announces Completion of Japan’s First Manufacturing Facility for Commercial Liposome Formulations
FUJIFILM Toyama Chemical
PR-M12-19-NI-015
Dec 10, 2019
Partnership
Fujifilm Expands RIS Revenue Cycle Solutions With Availity Partnership
FUJIFILM
PR-M06-18-NI-033
Jun 12, 2018
Viral Vector
Flexible, Mobile, Modular: High-Containment Viral Vector Center of Excellence
Thomas Page, Ph.D.
Fujifilm Diosynth Biotechnologies
PAP-Q2-18-CL-005
May 29, 2018
Expansion
Fujifilm Announces The Expansion Of Its Fill Finish Services
Fujifilm Diosynth Biotechnologies
PR-M05-18-NI-095
May 25, 2018
Acquistion
FUJIFILM Expands into Bio-Medical Business with Acquisition
Marc Technow
Nice Insight
PR-M03-18-NI-103
Mar 30, 2018
Imaging
Fujifilm Debuts ASPIRE Bellus II, A New Multimodality Mammography Workstation
FUJIFILM
PR-M03-18-NI-041
Mar 12, 2018
Investment
FUJIFILM Plans $1 Billion Capacity Expansion in U.S., U.K.
Nice Insight
PAO-M11-17-NI-029
Nov 17, 2017
1 / 1
